日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

The BEV1L study: Do real-world outcomes associated with the addition of bevacizumab to first-line chemotherapy in patients with ovarian cancer reinforce clinical trial findings?

BEV1L 研究:在卵巢癌患者的一线化疗中加入贝伐单抗的真实世界结果是否强化了临床试验结果?

Duska, Linda R; Lim, Jonathan; Calderón Boyle, Tirza Areli; Guinter, Mark; Halloran, Siobhan; Hartman, John; Schilder, Jeanne M; Hurteau, Jean A; Golembesky, Amanda K

Niraparib as First-Line Maintenance Therapy in Patients with Stage III Ovarian Cancer and No Visible Residual Disease: AR1ZE Real-World Study

尼拉帕尼作为一线维持治疗用于III期卵巢癌且无可见残留病灶的患者:AR1ZE真实世界研究

Chase, Dana M; Hanna, Maya; Lim, Jonathan T; Boyle, Tirza Areli Calderón; Guinter, Mark; Richey, Madeline; Patel, Khilna; Schilder, Jeanne M; Hurteau, Jean A; Golembesky, Amanda K

Real-world outcomes of first-line maintenance niraparib monotherapy in patients with epithelial ovarian cancer

一线维持尼拉帕尼单药治疗上皮性卵巢癌患者的真实世界疗效

Salani, Ritu; Calderón Boyle, Tirza Areli; Lim, Jonathan; Schilder, Jeanne M; Hurteau, Jean A; Perhanidis, Jessica; Golembesky, Amanda; Backes, Floor J

Sclerosing perineurioma of the anterior chest wall in an active Caucasian toddler: a case report

一名活跃的白人幼儿前胸壁硬化性神经周膜瘤:病例报告

Bettolli, Marcos; Hurteau, Julie; Haghandish, Nasim; Sergi, Consolato Maria

Identifying and breaking barriers: Addressing disparities in the care of patients with gynecologic cancers

识别并打破障碍:解决妇科癌症患者护理方面的差异

Pothuri, Bhavana; Muir, Michele; Hurteau, Jean; Farley, John; Lightfoot, Michelle D S; Dewdney, Summer; Castellano, Tara; Chan, John K; Ghamande, Sharad; Asante-Facey, Al; Stasenko, Marina; Rimel, B J; Paskett, Electra D

Characteristics and real-world outcomes of patients with epithelial ovarian cancer who received niraparib plus bevacizumab first-line maintenance therapy in the COMB1NE study

COMB1NE 研究中接受尼拉帕尼联合贝伐珠单抗一线维持治疗的上皮性卵巢癌患者的特征和真实世界结局

Thaker, Premal H; Areli Calderón Boyle, Tirza; Burns, Sara; Lim, Jonathan; Hartman, John; Kalilani, Linda V; Schilder, Jeanne M; Hurteau, Jean A; Golembesky, Amanda K

International circumpolar surveillance: update on the interlaboratory quality control program for Streptococcus pneumoniae, 2009 to 2020

国际环极监测:2009年至2020年肺炎链球菌实验室间质量控制计划最新进展

Golden, Alyssa R; Griffith, Averil; Simons, Brenna C; Reasonover, Alisa; Slotved, Hans-Christian; Lefebvre, Brigitte; Kristinsson, Karl G; Hurteau, Donna; Tyrrell, Gregory J; Bruce, Michael G; Martin, Irene

Estimating the influence of field inventory sampling intensity on forest landscape model performance for determining high-severity wildfire risk

评估实地清查抽样强度对森林景观模型确定高严重程度野火风险性能的影响

Hagar Hecht, Dan J Krofcheck, Dennis Carril, Matthew D Hurteau

Real-World First-Line Maintenance Niraparib Monotherapy Use Following Chemotherapy Plus Bevacizumab: The SW1TCH Study

真实世界中化疗联合贝伐单抗治疗后一线维持治疗尼拉帕尼单药治疗的应用:SW1TCH 研究

Rimel, Bobbie; Boyle, Tirza Areli Calderón; Burns, Sara; Lim, Jonathan; Hartman, John; Kalilani, Linda; Schilder, Jeanne M; Hurteau, Jean A; Golembesky, Amanda

Patient Characteristics Associated with Time to Next Treatment in Patients with Ovarian Cancer Treated with Niraparib: The PRED1CT Real-World Study

接受尼拉帕尼治疗的卵巢癌患者下次治疗时间相关的患者特征:PRED1CT 真实世界研究

Chase, Dana M; Shukla, Soham; Moore, Julia; Boyle, Tirza Areli Calderón; Lim, Jonathan; Perhanidis, Jessica; Hurteau, Jean A; Schilder, Jeanne M